CD274 and infantile convulsions and choreoathetosis: For example, the combined use of bevacizumab with chemotherapy or with anti-PD-1/PD-L1 drugs may lead to a synergistic response in reducing metastasis and improving the overall survival rates of iCCA patients [55,56].